StemcellUpdate

LifeCell International to Bring NxG Stem Cells Technology to India

LifeCell International, India's first and largest stem cell banking service provider, which has also pioneered in stem cell research and technology, recently announced its association with Harvest Technologies, a world leader in developing technologies that accelerate natural healing, to bring-in a next generation technology Bone Marrow Aspirate Concentrate (BMAC) system in India. BMAC is a USFDA and CE approved biological technology that accelerates the body's natural healing capacity, thereby improving surgical outcomes.

Existing methods to produce a stem cell concentrate therapy are time consuming, labour intensive, and require complex logistical considerations. The BMAC System helps in safe and rapid preparation of cell concentrate from bone marrow. The process takes only about 15 minutes and can be conducted in the point of care setting.

The system is currently being used clinically in many developed countries like the US and Europe for various medical disciplines. These applications range from fractures, non-unions, osteonecrosis, cartilage repair applications and Critical Limb Ischemia (CLI). The system will soon be applied for cardio vascular regeneration.

LifeCell has implemented this technology for an ongoing Indian CLI study which is being led by Dr KS Vijayragavan at Department of Vascular Surgery, SRMC. As per the data available on the interim study conducted on 30 patients after a 12 week follow-up major amputations were seen only in four patients and six of them went for minor amputation. The patients also reported significant reduction in their pain perception and considerable improvement in quality of life. The study also emphasised the fact that the BMAC process is safe and the Intra-arterial infusion does not cause any adverse reaction.

EH News Bureau